Skip to content
Clinical Trials for Alzheimer's Disease

Atlanta, Georgia

Alzheimer's disease clinical trials in Atlanta, GA

13 Alzheimer's disease studies are recruiting participants at sites in Atlanta as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Atlanta at a glance

  • 13 studies are recruiting at a site in Atlanta.
  • By phase: Phase 1 (1), Phase 2/3 (3), Phase 3 (5), No phase (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (7), university, hospital or other (6).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Atlanta

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Grady Memorial Hospital
    Registry record
    NCT07177352 · updated
  2. Adaptango Performance PRocess for Older Adults Community reHabilitation

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Study site
    Emory University, Executive Park, Wesley Woods
    Registry record
    NCT07824128 · updated
  3. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Agile Clinical Research Trials, LLC
    Registry record
    NCT05980949 · updated
  4. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Study site
    Agile Clinical Research Trials LLC
    Registry record
    NCT06159673 · updated
  5. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Agile Clinical Research Trials, LLC
    Registry record
    NCT07011745 · updated
  6. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Agile Clinical Research Trials, LLC
    Registry record
    NCT06585787 · updated
  7. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    Emory University School of Medicine
    Registry record
    NCT06563895 · updated
  8. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Emory University
    Registry record
    NCT05552157 · updated
  9. A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Emory University
    Registry record
    NCT06647498 · updated
  10. Moving Yourself in Space and Time: MYSTIC

    • No phase
    • Ages 18 to 79
    • All sexes
    Sponsor
    Emory University
    Study site
    Emory University, Executive Park, Wesley Woods
    Registry record
    NCT07697664 · updated
  11. A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

    • Phase 1
    • Ages 45 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Atlanta Center of Medical Research
    Registry record
    NCT06657768 · updated
  12. Inspiring Seniors Towards Exercise Promotion to Protect Cognition

    • No phase
    • Ages 65 and older
    • All sexes
    Sponsor
    Emory University
    Study site
    Emory University
    Registry record
    NCT06496425 · updated
  13. Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease

    • No phase
    • Ages 50 to 90
    • All sexes
    Sponsor
    Emory University
    Study site
    Emory Rehabilitation Hospital
    Registry record
    NCT06484244 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Atlanta, GA on ClinicalTrials.gov.

Ask about studies near Atlanta

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call